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At face value, the Sin3 histone deacetylase (HDAC) complex appears to be a prototypical
co-repressor complex, that is, a multi-protein complex recruited to chromatin by DNA
bound repressor proteins to facilitate local histone deacetylation and transcriptional
repression. While this is almost certainly part of its role, Sin3 stubbornly refuses to be
pigeon-holed in quite this way. Genome-wide mapping studies have found that Sin3 loca-
lises predominantly to the promoters of actively transcribed genes. While Sin3 knockout
studies in various species result in a combination of both up- and down-regulated genes.
Furthermore, genes such as the stem cell factor, Nanog, are dependent on the direct
association of Sin3 for active transcription to occur. Sin3 appears to have properties of a
co-repressor, co-activator and general transcription factor, and has thus been termed
a co-regulator complex. Through a series of unique domains, Sin3 is able to assemble
HDAC1/2, chromatin adaptors and transcription factors in a series of functionally and
compositionally distinct complexes to modify chromatin at both gene-speciﬁc and
global levels. Unsurprisingly, therefore, Sin3/HDAC1 have been implicated in the regulation
of numerous cellular processes, including mammalian development, maintenance of
pluripotency, cell cycle regulation and diseases such as cancer.
Histone acetylation: dynamic regulator of
chromatin accessibility
The long and fragile genomes of eukaryotic species are packaged into histones to form the more
robust chromatin ﬁbre. Chromatin allows the efﬁcient packaging of the genetic material but it also
forms a physical barrier to RNA polymerase and transcription factors which require access to the
DNA in order to initiate transcription. Therefore, to regulate access to the underlying DNA sequence,
histones undergo post-translational modiﬁcations (PTM), changing their chemical properties to open
or close chromatin [1]. One of the most common histone PTMs is Lysine acetylation (Lys-Ac). The
unstructured N-terminal tails of core histones (H2A, H2B, H3 and H4) are rich in Lys residues, which
being naturally positively charged, have an afﬁnity for the negatively charged DNA backbone.
Acetylation masks this negative charge, loosening the histone’s grip around DNA and opening the
chromatin to make it more transcriptionally permissible. In addition, Lys-Ac acts as a binding site for
proteins bearing a bromodomain [2], which for the most part include factors that help stimulate
transcription, thus reinforcing the positive nature of histone acetylation. By virtue of being a PTM of
histones, the genetic packaging material, acetylation is often referred to as an ‘epigenetic’ modiﬁcation.
This tends to be a semantic argument, depending on your deﬁnition of epigenetics, but there are a
couple points that often get overlooked in these discussions: (i) that the acetylome includes thousands
of proteins in addition to histones, with dozens of roles independent of gene regulation [3,4]; and (ii)
that histone acetylation is highly dynamic, with a typical half-life of ∼60–120 min [4,5], so if it does
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represent a code, it is a relatively short-lived one. The levels of Lys-Ac are regulated by the opposing action of
histone acetyltransferases (HATs) and histone deacetylases (HDACs). There are 18 HDACs in mammals
which can be categorised initially as having either Zn2+-dependent (Class I, II and IV) or NAD+-dependent
(Class III — Sirtuins) catalytic domains; and then further by the presence of additional N-terminal domains
and a tissue-speciﬁc expression pattern (Class II and IV) or a short C-terminal tail and ubiquitous expression
(Class I) (see [6–8] for extensive reviews). Although deacetylase enzymes almost certainly have thousands of
different protein substrates, and some may never enter the nucleus at all, we still tend to refer to them as
HDACs because histones remain the best-understood substrate for many of these enzymes. This particular
review will focus on class I HDACs, and the Sin3 complex in particular, which are targeted to chromatin by
multiple mechanisms and thus among all of the deacetylase enzymes, are probably most accurately named.
The complex world of HDAC1/2 function
The highly related deacetylases, HDAC1 and HDAC2 (HDAC1/2) share 82% amino acid identity and form the
catalytic core of numerous co-repressor complexes, which account for ∼50% of all cellular deacetylase activity in
embryonic stem (ES) cells [9] and T-cells [10]. The four canonical HDAC1/2 complexes are Sin3, NuRD,
CoREST and MiDAC [6,11–13]. These multi-protein complexes are critical to the function of HDAC1/2.
HDAC1/2 have reduced activity in the absence of a binding partner [14,15], and they are effectively blind,
requiring complex components to mediate the essential protein–protein interactions which guide them to
substrates. But why so many? Indeed, it is difﬁcult to think of another major enzyme that is part of four distinct
biochemical entities. The speciﬁcity of protein substrates, target genes and the combination of enzymatic activ-
ities (e.g. deacetylase/demethylase) may go some way to explaining the superabundance of HDAC1/2 complexes.
It is essential that the deacetylation machinery is not only tightly regulated, but highly speciﬁc. To date, we have
little understanding as to how this speciﬁcity is achieved, although it appears that it is driven by the holistic
action of the fully assembled complexes. We hypothesise that unique subunit within each complex help ‘present’
different protein targets to the HDAC1/2 catalytic site, through a combination of protein–protein interactions,
and/or histone recognition. Understanding the assembly of different subunits, within the holo-complex, is there-
fore critical to understanding the mechanism of its substrate recognition in vivo. The complex may also play a
role in the regulation of HDAC1/2 activity through the recognition of inositol phosphates (InsP). The
ELM2-SANT domain of MTA1 (part of the NuRD complex) contains speciﬁc and highly conserved basic resi-
dues which help co-ordinate the negatively charged phosphates in InsP6 [16]. These residues, and the stimula-
tion of the puriﬁed complex via InsP levels, appears to be conserved in the NuRD and MiDAC complexes
through their HDAC1/2 interacting subunits, MTA1 and MIDEAS, respectively [13]. The Sin3 complex
conspicuously lacks an ELM2-SANT domain and appears to be unique amongst HDAC1/2 complexes by being
insensitive to InsP in vitro [17]. Nonetheless, Sin3/HDAC1 remains a critical regulator of gene expression and as
discussed in detail below, is essential for embryo development and the differentiation of numerous tissue types.
The Sin3 co-regulator complex(es)
In many regards, Sin3 is the prototypical co-repressor complex, that is, a multi-protein complex recruited to
chromatin by DNA bound repressor proteins to facilitate local histone deacetylation and transcriptional repres-
sion [18–23]. While this is almost certainly part of its role, Sin3 stubbornly refuses to be pigeon-holed in quite
this way. Loss of Sin3 in yeast, fruit ﬂies and mice results in a combination of up- and down-regulated genes,
indicating roles in both transcriptional activation and repression [24–27]. Furthermore, genome-wide chroma-
tin immunoprecipitation (ChIP) studies also show Sin3 predominantly bound within the vicinity of transcrip-
tional start sites, not repressed loci [27,28]. HDAC1 activity [29] and the Sin3A complex [30] are also required
for full transcriptional activity of interferon-α responsive genes and Nanog promoter, respectively. Sin3 appears
to have properties of a co-repressor, co-activator and general transcription factor, and has thus been termed a
co-regulator complex [31].
The central platform of the complex is the Sin3 protein, which binds directly to HDAC1/2 and many other
adaptors [18,21,22], to assemble a functional, enzymatically active, Sin3 complex (Figure 1). Mammals contain
two highly related Sin3 proteins, Sin3A and Sin3B [32,33] which share an overall domain structure and an asso-
ciation with HDAC1/2. However, as will be discussed in detail below, mouse knockout (KO) studies have shown
them to be non-redundant and there is evidence that they form distinct protein complexes. Both proteins are
able to integrate signalling and transcription regulation by interacting with a host of transcription factors (REST,
Mxd1, PLZF, HBP1, etc.) which bind speciﬁcally to one of three paired-amphipathic helix (PAH) domains
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(Figure 1 and [32,34–36]). They are also recruited to chromatin through a series of Sin3-associated proteins
(SAP). These include, AT-rich interaction domain (ARID), tudor and chromodomain within Arid4A/B, a PHD
ﬁnger in Ing1/2 which bind directly to methylated Lys within histone tails and the histone chaperones, Rbbp4/7
[22,37–39]. In addition to deacetylase activity, Sin3A is also associated with DNA hydroxylases, Tet1 and Tet3
[28,40] and the O-GlcNAc transferase, OGT [41]; although, how these activities synergise with deacetylase activ-
ity is not fully understood. An extensive catalogue of SAPs can be found in the following studies [11,40,42–44].
Understanding how different SAPs co-operate to recruit the Sin3 complex to chromatin is a crucial step
towards understanding its functions in cells. With a dozen or more different SAPs it raises the question: are
they all bound at the same time? And if not, how many different variants of the Sin3 complex are there? To
address these questions Streubel et al. [43] employed two independent co-immunoprecipitation experiments
(with different antibodies), coupled to quantitative mass spectrometry, to assess the stoichiometry of individual
complex components. Intriguingly, given the panoply of available factors, it suggests the core-Sin3A complex
consists of Sin3A, Sap30, Rbbp4/7 and HDAC1 (preferentially over HDAC2). The notion that Sin3A may have
a preference for HDAC1 over HDAC2 is supported by data from T-cells, where a Sin3A/HDAC2 association
can only be detected following deletion of HDAC1 [10]. Also of note is the sub-stoichiometric nature of Suds3,
an essential gene thought to enhance the association of Sin3 with HDAC1 [45,46], which we might have
predicted to be closer to a 1 : 1 ratio with Sin3A. Suds3 may be interchangeable with the related factors,
Brms1/Brms1l [47,48], and that cumulatively all three proteins aid association with HDAC1 [49]. The majority
of SAPs (Tet1, OGT, SAP25, etc.) and transcription factors (Mxi1, Foxk1, etc.) have a relative stoichiometry
of <0.1 compared with Sin3A and therefore occupy only a fraction of the total Sin3A in cells, arguing that com-
petition for binding sites (e.g. Sap25 [50] and REST [51] for PAH1) may not be as prevalent as ﬁrst imagined.
If so, then multiple varieties of Sin3A complexes may exist contemporaneously in cells. Cell type may also
dictate complex composition, as the association of Fam60a, Tet1 and OGT all appear to be speciﬁc to ES cells,
rather than somatic cells [43]. The deﬁnition of a Sin3A complex may therefore be a moveable feast, consisting
of constitutive factors (HDAC1, Sap30, etc.) and a variety of sub-stoichiometric proteins and transcriptional
factors that are assembled dependent on the cell type.
CA
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Figure 1. Schematic of Sin3A/HDAC1 complex.
(A) Numbers indicate PAH domains 1–3. HID, HDAC-interaction domain; Sin3a_C, Sin3A C-terminal domain. Transcription
factor (red) binding to Sin3A occurs predominantly via PAH1 and 2 as indicated. Chromatin-associated proteins are coloured
orange and enzymes in green. (B) NMR structures of isolated PAH domains bound to the SID of the indicated factor. PAH
domains are shown in blue, SIDs in red and HID in purple. All data were taken from the Protein Data Bank (PDB code indicated
in brackets), SAP25:PAH1 (2RMS), REST:PAH1 (Sin3B, 2CZY), Mxd1:PAH2 (1G1E), HBP1:PAH2 (1S5R), Sap30:PAH3 (2LD7)
and Suds3:HID (2N2H). (C) Sin3 may be subdivided into two major complexes— Sin3L/Rpd3L (L— large) and Sin3S/Rpd3S
(small). In vivo, the Sin3A complex forms the scaffold of the larger Sin3L/Rpd3L complex, while Sin3B fulﬁls the same role in
the Sin3S/Rpd3S complex. * OGT binds to both Tet1 and Sin3A. ** Pf1 has two SID domains. Pf1 SID2 (PHD2) binds to PAH1,
while SID1 (PHD1) can interact with both MRG15 and PAH2 in a manner that is mutually exclusive. *** Arid4A (RBP1) can
associate with Sin3 via Sap30 [85], while binding of Arid4B (Sap180) was mapped to the HID [38].
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One well-studied sub-division among Sin3 complexes comes from work in yeast. Puriﬁcation of Sin3/Rpd3
(HDAC1) complexes identiﬁed two distinct biochemical entities of different apparent molecular mass, termed
Rpd3 large (Rpd3L: Sin3, Rpd3, Sap30, Sds3, Ume1, Ume6 and six other proteins) and Rpd3 small (Rpd3s:
Sin3, Rpd3, Ume1, Rco1 and Eaf3) [52,53]. Rpd3L seems to perform the classical co-repressor role being
recruited to gene-speciﬁc loci by transcription factors such as Ume6. While Rpd3S is recruited in the wake of
active RNA polymerase II, via the association of H3 Lys36 tri-methylation (H3K36me3) and the chromodo-
main of Eaf3, to repress cryptic promoters in actively transcribed regions. Loss of Eaf3 or Set2, the methyltrans-
ferase responsible for depositing H3K36me3, resulted in the activation cryptic promoters and the synthesis of
spurious transcripts [52]. The mammalian equivalent of Eaf3, Mrg15, was found to co-purify with Sin3B,
HDAC1 and Pf1 (Rco1s), but signiﬁcantly, not with Sin3A. Biochemical data from many studies suggests that
Sin3A may function as Sin3L/Rpd3L and Sin3B as Sin3S/Rpd3S. To cement this idea it is useful to compare
and contrast many complex puriﬁcation studies. Two different studies that utilised co-IP and mass spectrom-
etry of endogenous Sin3A complexes [40,43] failed to detect either Pf1 or Mrg15, which suggests they are not
major components of Sin3A complexes. While conversely, Nishibuchi et al. [54] performed Flag-Mrg15 co-IP
experiments in HeLa cells and were able to pulldown Sin3B, Pf1, Mrg15, HDAC1/2, KDM5A and EMSY, but
did not detect Sin3A, Sap30 or Suds3. Jelinic et al. [55] were able to reconstitute a mammalian tetrameric
complex equivalent to Rpd3S using Sin3B, HDAC1, Mrg15 (Eaf3) and Pf1 (Rco1), which they refer to as the
SHMP complex. Mrg15 recruitment into this complex requires Pf1, which in turn does not bind to Sin3A,
thereby establishing a binary distinction between the two complexes. Although Sin3A appears to form no part
of the Sin3S/Rpd3S complex, there is evidence to suggest that Sin3B may still form part of a Sin3L/Rpd3L
complex [56]. Intriguingly, Mrg15 and Eaf3 seem to act as double agents, being present in both HDAC and
HAT complexes [52,57,58], suggesting that the recognition of H3K36me3 could result in either histone
acetylation or deacetylation read-outs.
Sin3 domain structure: lessons from structural biology
The domain structure of Sin3A/B is highly conserved from yeast to man [32]. From N- to C-terminus, it con-
tains, three PAH domains (Pfam: PF02671), an HDAC-interaction domain (HID, Pfam: PF08295) and a Sin3A
C-terminal domain (Sin3a_C, Pfam: PF16879), formerly referred to as the highly conserved region (HCR
[59,60]), an eccentric term since much of the protein is highly conserved. Sin3a_C contains the region which pre-
viously included PAH4, a non-canonical PAH domain lacking critical protein–protein interacting residues [61].
Akin to the reclassiﬁcation of Pluto [62], the outermost PAH domain no longer fulﬁls the criteria required of its
inner neighbours. Both Sin3A and Sin3B share this modular arrangement of PAH1-3, HID and Sin3a_C. While
the two former domains have well-deﬁned roles discussed in detail below, the Sin3a_C region (887–1190 aa) is a
little more enigmatic. The binding site for OGT was mapped to Sin3A residues 888–967 [41], but OGT may also
be recruited to the complex via Tet1 and its association with PAH1 [63]. Structural biology has proved to be an
extremely powerful tool in understanding the molecular details of these Sin3 domains.
PAH domains: under lock-and-key
The three PAH domains are imperfect ∼100 amino acid repeats with a conserved fold, consisting of four
α-helices separated into pairs by a central loop [35,51,61,64–66] (Figure 1). These amphipathic helices arrange
themselves to form a hydrophobic cleft into which the single helix Sin3-interaction domain (SID) of the inter-
acting partner is able to insert and bind with high afﬁnity. The PAH domains act as critical protein–protein
docking sites, permitting the formation of Sin3 complexes by allowing multiple transcription factors and
chromatin-associated factors to recruit the core deacetylase activity [19,32,43,56,67]. The ﬁrst structural studies
of a PAH:SID interaction were performed with proteins of the Mxd1 family, the original baits used in two-
hybrid screens to isolate mammalian Sin3 [32,33], bound to PAH2 of Sin3A [61] and Sin3B [65]. These
revealed a highly conserved set of hydrophobic interactions, with critical residues in helix1 (Ile308/Val311) and
helix2 (Leu329/Leu332) of Sin3A-PAH2 accommodating those of the Mxd1-SID (Leu12/Ala15/Ala16) [68]. An
analogous set of interactions occurs between helices 1 and 2 of PAH1 with the SIDs of REST [51] and Sap25
[64] (Figure 1). One signiﬁcant difference between the two domains is that Sin3A-PAH1 is largely structured in
the absence of a SID, whereas Sin3A-PAH2 is not; the latter undergoing a mutual folding transition with its
ligand upon binding. Interestingly, the analogous folding transition in Sin3B-PAH2 is limited to residues in
helix1 [65]. Although PAH1 and PAH2 are thought to function as independent domains [69], there is also
some evidence for cooperativity, since mutations in PAH1 can affect binding of the Mxd1-SID to PAH2 [68],
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despite not binding to PAH1. Unlike PAH1 and 2, which engage in sub-stoichiometric interactions with a
range of transcription factors and chromatin-associated proteins, PAH3 (of Sin3A) is constitutively bound to
Sap30 [43]. The PAH3/Sap30 structure has many unique features including a tri-partite Sap30-SID, which
interacts with both the canonical hydrophobic cleft and an additional hydrophobic surface on the side of
PAH3 [70]. Consistent with the constitutive nature of their association, PAH3/Sap30 have the highest afﬁnity
of any PAH/SID combination (∼10 nM) thus far measured.
All three PAH domains show a signiﬁcant degree of similarity and yet the speciﬁcity of interacting partners
is quite distinct. The Mxd1-SID binds PAH2 but does not interact with PAH1 or 3 [64,68]; while the
SAP25-SID binds to PAH1 but not PAH2 or 3 [50,64]. This speciﬁcity is derived from the unique arrangement
of long and short hydrophobic side-chains which from a unique lock-and-key interaction for each combination
of PAH:SID. These high-afﬁnity hydrophobic interactions (typical Kd in the sub-micromolar region,
50–200 nM) are guided by long-range electrostatic interactions. van Ingen et al. [71] observed that addition of
a four amino acid sequence (Arg/Arg/Glu/Arg) to the Mxd1-SID improved the Kd from 1.4 mM (Mxd1
5–20aa) to 0.4 mM (Mxd1 5–24aa). The increased afﬁnity was the result of a long-range electrostatic attraction
between Sin3B Lys165 (which sits above the hydrophobic cleft) and Mxd1 Glu23. An N:O bridge forms
through hydrogen bonding which orients the SID for binding and brings it close enough to the PAH domain
for the relatively short range hydrophobic interaction to occur. Sin3A-PAH2 contains an equivalent Lys
residue, Lys315, whose charge also contributes to the binding of the Mxd1-SID [61], suggesting a conserved
manner of recruitment to Sin3A and Sin3B in this instance. Electrostatic interactions also contribute to the
association of PAH1, PAH3 and HID with their binding partners [49,64,70].
In closing this section, it may be useful to reﬂect on the usage of the PAH domains. Data from Streubel
et al. show that Sap30 is present in a 1 : 1 complex with Sin3A suggesting that PAH3 may be permanently
occupied [43]. This would leave the majority of the burden (numerically at least) on PAH1 and PAH2 to
mediate binding with upwards of 20 different interacting partners. If the aim were to inhibit the Sin3A
complex therapeutically, as an alternative method of HDAC inhibition in cells, then this would be a logical
place to start. Indeed, many studies from Waxman and colleagues have shown that selective inhibition of
PAH2 with an interfering peptide derived from the Mxd1-SID termed, SID-decoy, reduces the growth of triple
negative breast cancer (TNBC) cells [72]. Interference with Sin3 function induces epigenetic reprogramming
and differentiation in breast cancer cells through de-repression of E-cadherin, oestrogen receptor alpha (ERα)
and retinoic acid receptor alpha (RARα). An in silico screen of small molecule inhibitor mimetics identiﬁed
FDA-approved avermectin derivatives as PAH2 binders [73] which phenocopied the SID-decoy and, in con-
junction with a RARα agonist, prevented metastases and improved survival following tumour removal in
TNBC model mice — highlighting the potential therapeutic role of Sin3 inhibitors in cancer treatment [74].
The HID: the enzymatic core
The binding site for HDAC1 in Sin3A was initially mapped between PAH3 and PAH4 (still a domain in 1997)
and duly named the HID [21]. This is a HCR in Sin3A/B and across different species, the size of a moderate
protein (∼300 aa) which mediates interactions with the aforementioned HDAC1, as well as HDAC2, Suds3,
Brms1, Brmsl1, MRG15, Sap130, Arid4B (Sap180) and Rbbp4/7 [38,47,48,75,76]. Although some of these asso-
ciations are clearly direct (e.g. Suds3:HID) [49], others may be indirect, MRG15 requires the presence of Pf1 to
bind to Sin3B for instance [55]. The presumptive role for this gaggle of associations is to stabilise the Sin3/
HDAC1 interaction. And in addition, recruit the complex to chromatin via MRG15 (Chromodomain) [77],
Arid4A/B (ARID, Tudor and Chromodomain) [38] and the histone chaperones, Rbbp4/7 (WD40 domain) [78].
This latter role may occur based on the presence of the appropriate histone, or histone modiﬁcation and repre-
sents a method of Sin3A/HDAC1 recruitment independent of the transcription factor:PAH domain interactions
described above. As already discussed, Suds3, Brms1 and Brms1l are paralogues that share structural and
sequence homology (SDS3-like, Pfam: PF08598) including two coiled-coil regions and a C-terminal SID [49],
suggesting that their roles may be interchangeable. In Saccharomyces cerevisiae, which contains a single Suds3
gene, deletion causes dissociation of Sin3 and HDAC1 (Rpd3), and the remaining HDAC1 is enzymatically
inactive [46]. Deletion of Suds3 is embryonic lethal in mice and produces defects in pericentric heterochromatin
in ﬁbroblasts [45], indicating that it has non-redundant roles with Brms1/Brms1l. The presence of a coiled-coil
domain in all three proteins indicates that the Sin3A complex is likely to be a dimer; indeed, Suds3 and BRMS1
are able to form both homo- and heterodimers [49]. Dimerisation is a common feature of HDAC1/2 complexes
[13], which may reﬂect the presence of two N-terminal tails for each core histone within the nucleosome.
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A solution structure of the Suds3-SID bound to a portion of the HID (Sin3A 601–742 aa) has been described
with a sub-micromolar afﬁnity [49]. Characteristic of other Sin3:SAP interactions, it consists of a multi-helical
Sin3 domain bound to an extended single helix domain of the partner. In this instance, the HID forms a
six-helix bundle in which the two longest helices (α1 and α5) form an intramolecular coiled-coil stalk, that the
shorter helices (α2, α3 and α4) pack against to form a globular head (Figure 1). The Suds3-SID (201–234 aa)
consists of an extended N-terminal segment immediately followed by a 13-residue helix, with the latter making
extensive hydrophobic and a few key electrostatic contacts with the globular head of the HID. Intriguingly,
Clark et al. [49] found that recruitment of HDAC1 to the Sin3A-HID was independent of Suds3, an unex-
pected result given previous data from yeast [46]. However, given the close proximity of their binding sites
within the HID it still seems likely that there may be some complementary, although non-essential, contacts
between Suds3 and HDAC1. Structural information of a Sin3/Suds3/HDAC1 ternary complex would surely
answer many of these molecular details and is eagerly anticipated.
The physiological roles of mammalian Sin3 complexes
The Sin3/HDAC complex is abundant, stable and ubiquitously expressed in mammalian tissues and cells. The
temporal and cell type-speciﬁc nature of its activity, in numerous cellular processes, is mediated via transient
association with transcription factors. Sin3 can therefore be viewed as a permanent tool in the chromatin
toolbox, which can be recruited to speciﬁc loci and then applied to regulate chromatin accessibility in particular
pathways by tissue-speciﬁc factors which interact with PAH, HID or Sin3a_C domains. Since its initial discov-
ery as a transcriptional repressor of Myc target genes, via the association of PAH2 and Mxd1, Sin3 has been
associated with numerous cellular processes, including mammalian development, maintenance of pluripotency,
cell survival, cell cycle regulation (summarised in Figure 2) and diseases such as cancer.
Distinct roles for Sin3A and Sin3B in cell cycle and
DNA replication
The cell cycle is regulated at every stage (G1/S restriction point, DNA replication, G2/M check-point, mitosis)
and Sin3 appears to play a role in each of them. The implication that Sin3 had a role to play in cell cycle was
clear from the outset. Mxd1 (formerly Mad1) and Mxi1 are repressor proteins which compete with Myc for
their common heterodimeric partner, Max, and form an anti-proliferative counter-weight to the pro-growth
role of Myc [79]. Yeast two-hybrid screens performed with Mxd1/Mxi1 identiﬁed mammalian Sin3A and
Sin3B as a cognate co-repressor; with later studies conﬁrming that interaction with Sin3 (via PAH2) was
required for both repression and regulation of cell cycle [32,33,80]. Latterly, Sin3 was found to be associated
with many cell cycle regulators, including the master regulator of G1/S transition, retinoblastoma protein (Rb).
Rb can itself be viewed as a co-repressor protein, which sits atop the E2F family of transcription factors, nega-
tively regulating target genes preventing entry into S-phase [81]. Rb was initially demonstrated to perform this
role by recruiting HDAC1 [82–84] and latterly this was shown to be as part of the Sin3A/HDAC1 complex,
recruited via Arid4A (previously RBP1) and Sap30 [85]. The association of Sin3A/HDAC1 with Rb and the
Mxd1 family suggests that loss of Sin3A would cause cells to cycle uncontrollably, but in fact the opposite is
the case. Sin3A-KO studies in mouse embryo ﬁbroblasts (MEFs), ES and T-cells have shown that a reduction
in Sin3A levels correlates with a loss of proliferative potential [25,40,86]. This is perhaps not wholly surprising
as the treatment of cells with HDAC inhibitors, such as SAHA or MS-275 (which speciﬁcally target class I
HDACs), universally results in a loss of cell growth [87]. Similarly, double deletion of HDAC1/2 in MEFs
causes an arrest in G1 due to the up-regulation of the CDK inhibitors, p21 and p57 [88,89]; up-regulation of
p21 is also observed in Sin3A-KO MEFs [25]. Despite a loss of cell proliferation, Sin3B protein levels are
unaltered in Sin3A-KO MEFs conﬁrming distinct roles in cell cycle [25,86,90]. Although Sin3B-KO MEFs
reveal no cell cycle defects, they fail to exit the cell cycle upon loss of serum in a similar manner to Rb null
MEFs [91], suggesting Sin3B may be regulating cell cycle exit [92]. Moreover, loss of Sin3B in MEFs results in
the absence of senescence upon oncogenic stress, while overexpression of Sin3B promotes cell cycle exit [93].
Sin3B/HDAC1 are co-localised with E2F4, p107, p130 at target genes such as cyclin A and E2F1 in quiescent
cells to prevent re-entry into cell cycle [94].
Replication of the genome is an essential and rate-limiting phase of cell cycle. Critically, new DNA requires
new chromatin. Histone H4 is initially deposited on nascent DNA in an acetylated form (H4K5ac/H4K12ac
[95,96]) which must be deacetylated before the pattern of pre-replication PTMs can be reapplied. iPOND
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(isolation of proteins on nascent DNA), a technique which utilises EdU incorporation into DNA to label and
purify proteins close to replisomes, identiﬁed HDAC1/2 and 3 as being present close to the replication fork
[97]. Consistent with this data, loss of HDAC1/2 causes a reduction in the rate of DNA replication/fork velocity
and a propensity for defects in fork progression [98]. Although these studies do not implicate the Sin3A
complex directly, it seems a likely candidate among the stable of HDAC1/2 complexes. Tantalisingly,
Dannenberg et al., observed a reduction in S-phase cells in Sin3A-KO MEFs, with a distinct subset of cells
which had no BrdU incorporation [25]. An accumulation of errors during S-phase may contribute to the
increase in Sin3A-KO cells in G2/M. KO of the Sin3A component, Suds3, also causes G2/M arrest and
profound aneuploidy due to a perturbation in chromosome segregation [45]. This is reminiscent of Sin3-KOs
in Schizosaccharomyces pombe [99], with both the mammalian and yeast phenotypes thought to occur due to
the aberrant acetylation of pericentric heterochromatin, which ultimately causes the mitotic defects. A similar
G2/M arrest is found in ES cells lacking Sin3A, with the subsequent triggering of the DNA damage response
[40]. In summary, Sin3 complexes combine regulation of individual target genes (Rb-E2F axis, Myc/Mxd
network, etc.) with house-keeping roles as a global chromatin rheostat (DNA replication, peri-centric
heterochromatin, etc.) in the progression of (or exit from) cell cycle.
Sin3 complexes are essential for embryogenesis and stem
cell pluripotency
Although Sin3A and Sin3B are 57% identical [32] and share a conserved domain structure they have unique
functions during development. Sin3B-KO mice show lethality during the later stages of embryonic
development and display defects in erythrocytes and bone differentiation beyond embryonic day (E)14.5 [92].
Figure 2. Representation of the physiological roles of Sin3 complexes in mammalian cells and tissue development.
Inner ring represents the cellular process, with the outer rings denoting the speciﬁc complex functions. Processes in which
Sin3A (blue), Sin3B (green) or both (orange) have been implicated are indicated.
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These defects in terminal differentiation can be linked to the role of Sin3B/HDAC1 in cell cycle exit [90]. In
contrast, Sin3A-KO embryos are not found after E6.5 [25,86]. Cultured Sin3A-KO blastocysts (E3.5) have a
reduced proliferative potential suggesting that either cell cycle or pluripotency is impaired [86]. However, most
Sin3A null embryos still undergo implantation, but by E5.5 few embryos were detected and these had com-
pletely lost their embryonic compartment [40]. The different phenotypes displayed by Sin3A and Sin3B-KO
models reveals a lack of redundancy, in agreement with the unique biochemical and cell cycle activities
discussed above.
Consistent with early embryonic lethality in mice, Sin3A has been reported to be crucial for the maintenance
of pluripotency in ES cells [30,40,42,43,100,101]. Indeed, Sin3A levels are conspicuously high in ES cells, with a
reduction occurring following differentiation [42,101]. A reduction in Sin3A levels also caused an extended
G1-phase in ES cells [43,101], which is a critical determinant of self-renewal versus lineage commitment. The
absence of Sin3A, or HDAC1/2, resulted in a down-regulation of the key pluripotent regulator, Nanog [30].
ChIP experiments showed that Sin3A binds directly to a Nanog enhancer suggesting it is required for transcrip-
tional activity for key elements of the pluripotent network of transcription factors. In addition to maintaining
pluripotency, Nanog and the Sin3A complex are able to associate and promote the reprogramming of somatic
cells into induced pluripotent cells [42]. Streubel et al., identiﬁed an ES cells speciﬁc Sin3A complex which
includes Tet1, OGT and Fam60a [43]. Loss of Fam60a caused a signiﬁcant reduction in the recruitment of
Sin3A to target genes identifying this cofactor as a critical determinant for target gene recruitment.
Unsurprisingly therefore, knockdown of either Sin3A or Fam60a caused a reduction in cell proliferation and
pluripotency. The 5-methyl cytosine (5mC) hydroxylase, Tet1, while not essential for the maintenance of pluri-
potency itself, is recruited to Sin3A via PAH1 [63,101] and appears to co-operate in the regulation of key ES
cell signalling pathways [101]. Sin3A helps recruit Tet1 to genes such as the Nodal antagonist, Lefty1, maintain-
ing its transcriptional activity and thus preventing commitment towards a mesendodermal lineage. However,
ectopic expression Lefty1 alone is not able to rescue the Sin3A knockdown phenotype indicating that there are
additional targets of the Sin3A/Tet1 partnership.
Sin3 in tissue development
Sin3A and Sin3B are highly expressed in all tissues (although absolute levels may vary a little). As permanent
members of the chromatin toolbox, they can be recruited by a wide variety of tissue-speciﬁc transcription
factors during tissue development. It is therefore unsurprising that KO studies have identiﬁed key roles for both
proteins in a variety of tissue types. Sin3A/B are critical for the maintenance of haematopoietic stem cell
homeostasis, with the different isoforms of Sin3 potentially regulating alternative pathways via unique interac-
tions with transcription factors. Loss of Sin3A in the bone marrow of mice results in a reduction in haemato-
poietic stem cells and subsequent lineages indicating a defect in early haematopoiesis [102]. Deletion of Sin3B
in the haematopoietic lineage in mice led to elevated numbers of multipotent progenitors of haematopoietic
stem cells with defects in their terminal differentiation potential, but had no effect on cell viability [90]. Sin3A
has also been implicated in T-cell development. Deletion of Sin3A in early T-cells using Lck-Cre caused a
3-fold increase in double negative (DN) T-cells and a concomitant reduction in cellularity, indicating a block
in thymopoiesis [86]. Conditional deletion of Sin3A in the myotube using Myf5-Cre results in perinatal lethal-
ity 24 h after birth, while the analogous Sin3B-KO mice survive for up to 2 years, indicating distinct effects on
muscle differentiation [103]. Moreover, MCK-Cre driven loss of Sin3A in skeletal progenitors results in lethality
at 12 days due to disorganised sarcomeres, while Sin3B-KO mice are viable. Interestingly a double KO of Sin3A
and Sin3B results in an enhanced phenotype suggesting partial redundancy [103]. Analysis of muscle develop-
ment genes and adhesion complexes revealed reduced expression upon deletion of Sin3A or Sin3A/B, but not
Sin3B alone, suggesting Sin3A may be acting to enable their expression and maintain sarcomere formation.
Sin3A has also been implicated in male germ cell development as conditional KOs (Vasa-Cre) results in sterile
male mice with a sertoli only phenotype at day 10 postnatal (lacking germ cells, as marked by TRA98 and
GCNA1 staining) [104]. Interestingly, analysis of postnatal pups at day 1–3 reveals germ cells are present in the
testes suggesting that Sin3A is not needed for differentiation but for maintenance of germ cell viability. This is
further supported by enhanced caspase-3 expression and DNA damage in germ cells as they re-enter mitosis
after birth [104]. The authors linked the phenotype to up-regulation of c-Myc genes due to reduced
Mxd-family repression via Sin3A and enhanced DNA damage. Finally, Sin3A plays a critical role during lung
development, as loss of activity in the early foregut endoderm of the developing mouse leads to widespread
defects and neonatal death [105]. Defects included down-regulation of endodermal genes and induction of a
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senescent-like state, consistent with up-regulation of cell cycle inhibitors p16 and p21, further supporting the
role of Sin3A in cell cycle regulation.
Future perspectives
As both global chromatin regulator and gene-speciﬁc transcriptional co-regulator, the Sin3 complex, or rather
complexes, play roles in all nuclear processes. The ﬂexibility of multiple direct protein–protein interfaces (PAH,
HID and Sin3a_C domains) and a multitude of cofactors (Tet1, OGT, Arid4A, Ing2, etc.) allow its recruitment
for the regulation of chromatin homeostasis throughout the cell cycle. Any process which requires access to
DNA (transcription, DNA replication and/or repair) will require the manipulation of histone acetylation and as
a major HDAC complex, Sin3 will likely play a role. Understanding the complex set of protein–protein interac-
tions, and perhaps teasing these apart as a targeted therapy, will drive Sin3 biology for many years to come.
Abbreviations
ARID, AT-rich interaction domain; ChIP, chromatin immunoprecipitation; DN, double negative; ES, embryonic
stem; HATs, histone acetyltransferases; HCR, highly conserved region; HDACs, histone deacetylases; HDAC1/2,
histone deacetylase 1 and 2; HID, HDAC-interaction domain; KO, knockout; Lys-Ac, lysine acetylation; MEFs,
mouse embryo ﬁbroblasts; OGT, O-GlcNAc transferase; PAH, paired-amphipathic helix; PTM, post-translational
modiﬁcations; RARα, retinoic acid receptor alpha; SAP, Sin3-associated proteins; SID, Sin3-interaction domain;
TNBC, triple negative breast cancer.
Acknowledgements
We thank Dr Richard Kelly, Dr Chia-Liang Lin and members of the Cowley laboratory for useful discussions
and comments on the manuscript. S.M.C. is supported by a senior non-clinical fellowship from the MRC
[MR/J009202/1] and BBSRC project grants [BB/N002954/1, BB/P021689/1].
Competing Interests
The Authors declare that there are no competing interests associated with the manuscript.
References
1 Kouzarides, T. (2007) Chromatin modiﬁcations and their function. Cell 128, 693–705 https://doi.org/10.1016/j.cell.2007.02.005
2 Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J.P., Barsyte-Lovejoy, D. et al. (2012) Histone recognition and large-scale structural
analysis of the human bromodomain family. Cell 149, 214–231 https://doi.org/10.1016/j.cell.2012.02.013
3 Choudhary, C., Weinert, B.T., Nishida, Y., Verdin, E. and Mann, M. (2014) The growing landscape of lysine acetylation links metabolism and cell
signalling. Nat. Rev. Mol. Cell Biol. 15, 536–550 https://doi.org/10.1038/nrm3841
4 Weinert, B.T., Narita, T., Satpathy, S., Srinivasan, B., Hansen, B.K., Schölz, C. et al. (2018) Time-resolved analysis reveals rapid dynamics and broad
scope of the CBP/p300 acetylome. Cell 174, 231–244.e212 https://doi.org/10.1016/j.cell.2018.04.033
5 Zheng, Y., Thomas, P.M. and Kelleher, N.L. (2013) Measurement of acetylation turnover at distinct lysines in human histones identiﬁes long-lived
acetylation sites. Nat. Commun. 4, 2203 https://doi.org/10.1038/ncomms3203
6 Kelly, R.D. and Cowley, S.M. (2013) The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts.
Biochem. Soc. Trans. 41, 741–749 https://doi.org/10.1042/BST20130010
7 Seto, E. and Yoshida, M. (2014) Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb. Perspect. Biol. 6, a018713
https://doi.org/10.1101/cshperspect.a018713
8 Yang, X.J. and Seto, E. (2008) The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat. Rev. Mol. Cell Biol.
9, 206–218 https://doi.org/10.1038/nrm2346
9 Jamaladdin, S., Kelly, R.D., O’Regan, L., Dovey, O.M., Hodson, G.E., Millard, C.J. et al. (2014) Histone deacetylase (HDAC) 1 and 2 are essential for
accurate cell division and the pluripotency of embryonic stem cells. Proc. Natl Acad. Sci. U.S.A. 111, 9840–9845 https://doi.org/10.1073/pnas.
1321330111
10 Dovey, O.M., Foster, C.T., Conte, N., Edwards, S.A., Edwards, J.M., Singh, R. et al. (2013) Histone deacetylase 1 and 2 are essential for normal T-cell
development and genomic stability in mice. Blood 121, 1335–1344 https://doi.org/10.1182/blood-2012-07-441949
11 Bantscheff, M., Hopf, C., Savitski, M.M., Dittmann, A., Grandi, P., Michon, A.M. et al. (2011) Chemoproteomics proﬁling of HDAC inhibitors reveals
selective targeting of HDAC complexes. Nat. Biotechnol. 29, 255–265 https://doi.org/10.1038/nbt.1759
12 Itoh, T., Fairall, L., Muskett, F.W., Milano, C.P., Watson, P.J., Arnaudo, N. et al. (2015) Structural and functional characterization of a cell cycle
associated HDAC1/2 complex reveals the structural basis for complex assembly and nucleosome targeting. Nucleic Acids Res. 43, 2033–2044
https://doi.org/10.1093/nar/gkv068
13 Millard, C.J., Watson, P.J., Fairall, L. and Schwabe, J.W.R. (2017) Targeting class i histone deacetylases in a ‘complex’ environment. Trends Pharmacol.
Sci. 38, 363–377 https://doi.org/10.1016/j.tips.2016.12.006
14 Zhang, Y., Ng, H.H., Erdjument-Bromage, H., Tempst, P., Bird, A. and Reinberg, D. (1999) Analysis of the NuRD subunits reveals a histone deacetylase
core complex and a connection with DNA methylation. Genes Dev. 13, 1924–1935 https://doi.org/10.1101/gad.13.15.1924
© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY). 3929
Biochemical Journal (2018) 475 3921–3932
https://doi.org/10.1042/BCJ20170314
15 Millard, C.J., Watson, P.J., Celardo, I., Gordiyenko, Y., Cowley, S.M., Robinson, C.V. et al. (2013) Class I HDACs share a common mechanism of
regulation by inositol phosphates. Mol. Cell 51, 57–67 https://doi.org/10.1016/j.molcel.2013.05.020
16 Watson, P.J., Millard, C.J., Riley, A.M., Robertson, N.S., Wright, L.C., Godage, H.Y. et al. (2016) Insights into the activation mechanism of class I HDAC
complexes by inositol phosphates. Nat. Commun. 7, 11262 https://doi.org/10.1038/ncomms11262
17 Portolano, N. (2015) Investigation of the Sin3a-HDAC1-SDS3 Transcriptional co-Repressor Complex, EThOS. https://ethos.bl.uk/OrderDetails.do?uin=uk.
bl.ethos.643678nnnnnn
18 Hassig, C.A., Fleischer, T.C., Billin, A.N., Schreiber, S.L. and Ayer, D.E. (1997) Histone deacetylase activity is required for full transcriptional repression
by mSin3A. Cell 89, 341–347 https://doi.org/10.1016/S0092-8674(00)80214-7
19 Kadosh, D. and Struhl, K. (1997) Repression by Ume6 involves recruitment of a complex containing Sin3 corepressor and Rpd3 histone deacetylase to
target promoters. Cell 89, 365–371 https://doi.org/10.1016/S0092-8674(00)80217-2
20 Kadosh, D. and Struhl, K. (1998) Targeted recruitment of the Sin3-Rpd3 histone deacetylase complex generates a highly localized domain of repressed
chromatin in vivo. Mol. Cell. Biol. 18, 5121–5127 https://doi.org/10.1128/MCB.18.9.5121
21 Laherty, C.D., Yang, W.M., Sun, J.M., Davie, J.R., Seto, E. and Eisenman, R.N. (1997) Histone deacetylases associated with the mSin3 corepressor
mediate mad transcriptional repression. Cell 89, 349–356 https://doi.org/10.1016/S0092-8674(00)80215-9
22 Zhang, Y., Iratni, R., Erdjument-Bromage, H., Tempst, P. and Reinberg, D. (1997) Histone deacetylases and SAP18, a novel polypeptide, are
components of a human Sin3 complex. Cell 89, 357–364 https://doi.org/10.1016/S0092-8674(00)80216-0
23 Vermeulen, M., Carrozza, M.J., Lasonder, E., Workman, J.L., Logie, C. and Stunnenberg, H.G. (2004) In vitro targeting reveals intrinsic histone tail
speciﬁcity of the Sin3/histone deacetylase and N-CoR/SMRT corepressor complexes. Mol. Cell. Biol. 24, 2364–2372 https://doi.org/10.1128/MCB.24.6.
2364-2372.2004
24 Bernstein, B.E., Tong, J.K. and Schreiber, S.L. (2000) Genomewide studies of histone deacetylase function in yeast. Proc. Natl Acad. Sci. U.S.A.
97, 13708–13713 https://doi.org/10.1073/pnas.250477697
25 Dannenberg, J.H., David, G., Zhong, S., van der Torre, J., Wong, W.H. and Depinho, R.A. (2005) Msin3a corepressor regulates diverse transcriptional
networks governing normal and neoplastic growth and survival. Genes Dev. 19, 1581–1595 https://doi.org/10.1101/gad.1286905
26 Pile, L.A., Spellman, P.T., Katzenberger, R.J. and Wassarman, D.A. (2003) The SIN3 deacetylase complex represses genes encoding mitochondrial
proteins: implications for the regulation of energy metabolism. J. Biol. Chem. 278, 37840–37848 https://doi.org/10.1074/jbc.M305996200
27 Saha, N., Liu, M., Gajan, A. and Pile, L.A. (2016) Genome-wide studies reveal novel and distinct biological pathways regulated by SIN3 isoforms.
BMC Genomics 17, 111 https://doi.org/10.1186/s12864-016-2428-5
28 Williams, K., Christensen, J., Pedersen, M.T., Johansen, J.V., Cloos, P.A., Rappsilber, J. et al. (2011) TET1 and hydroxymethylcytosine in transcription
and DNA methylation ﬁdelity. Nature 473, 343–348 https://doi.org/10.1038/nature10066
29 Nusinzon, I. and Horvath, C.M. (2003) Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone
deacetylase 1. Proc. Natl Acad. Sci. U.S.A. 100, 14742–14747 https://doi.org/10.1073/pnas.2433987100
30 Baltus, G.A., Kowalski, M.P., Tutter, A.V. and Kadam, S. (2009) A positive regulatory role for the mSin3A-HDAC complex in pluripotency through Nanog
and Sox2. J. Biol. Chem. 284, 6998–7006 https://doi.org/10.1074/jbc.M807670200
31 Chaubal, A. and Pile, L.A. (2018) Same agent, different messages: insight into transcriptional regulation by SIN3 isoforms. Epigenetics Chromatin 11,
17 https://doi.org/10.1186/s13072-018-0188-y
32 Ayer, D.E., Lawrence, Q.A. and Eisenman, R.N. (1995) Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian
homologs of yeast repressor Sin3. Cell 80, 767–776 https://doi.org/10.1016/0092-8674(95)90355-0
33 Schreiber-Agus, N., Chin, L., Chen, K., Torres, R., Rao, G., Guida, P. et al. (1995) An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic
activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80, 777–786 https://doi.org/10.1016/0092-8674(95)90356-9
34 David, G., Alland, L., Hong, S.H., Wong, C.W., DePinho, R.A. and Dejean, A. (1998) Histone deacetylase associated with mSin3A mediates repression
by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16, 2549–2556 https://doi.org/10.1038/sj.onc.1202043
35 Swanson, K.A., Knoepﬂer, P.S., Huang, K., Kang, R.S., Cowley, S.M., Laherty, C.D. et al. (2004) HBP1 and Mad1 repressors bind the Sin3 corepressor
PAH2 domain with opposite helical orientations. Nat. Struct. Mol. Biol. 11, 738–746 https://doi.org/10.1038/nsmb798
36 Grimes, J.A., Nielsen, S.J., Battaglioli, E., Miska, E.A., Speh, J.C., Berry, D.L. et al. (2000) The co-repressor mSin3A is a functional component of the
REST-CoREST repressor complex. J. Biol. Chem. 275, 9461–9467 https://doi.org/10.1074/jbc.275.13.9461
37 Doyon, Y., Cayrou, C., Ullah, M., Landry, A.J., Côté, V., Selleck, W. et al. (2006) ING tumor suppressor proteins are critical regulators of chromatin
acetylation required for genome expression and perpetuation. Mol. Cell 21, 51–64 https://doi.org/10.1016/j.molcel.2005.12.007
38 Fleischer, T.C., Yun, U.J. and Ayer, D.E. (2003) Identiﬁcation and characterization of three new components of the mSin3A corepressor complex.
Mol. Cell. Biol. 23, 3456–3467 https://doi.org/10.1128/MCB.23.10.3456-3467.2003
39 Kuzmichev, A., Zhang, Y., Erdjument-Bromage, H., Tempst, P. and Reinberg, D. (2002) Role of the Sin3-histone deacetylase complex in growth
regulation by the candidate tumor suppressor p33(ING1). Mol. Cell. Biol. 22, 835–848 https://doi.org/10.1128/MCB.22.3.835-848.2002
40 McDonel, P., Demmers, J., Tan, D.W., Watt, F. and Hendrich, B.D. (2012) Sin3a is essential for the genome integrity and viability of pluripotent cells.
Dev. Biol. 363, 62–73 https://doi.org/10.1016/j.ydbio.2011.12.019
41 Yang, X., Zhang, F. and Kudlow, J.E. (2002) Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein
O-GlcNAcylation to transcriptional repression. Cell 110, 69–80 https://doi.org/10.1016/S0092-8674(02)00810-3
42 Saunders, A., Huang, X., Fidalgo, M., Reimer, Jr., M.H., Faiola, F., Ding, J. et al. (2017) The SIN3A/HDAC corepressor complex functionally cooperates
with NANOG to promote pluripotency. Cell Rep. 18, 1713–1726 https://doi.org/10.1016/j.celrep.2017.01.055
43 Streubel, G., Fitzpatrick, D.J., Oliviero, G., Scelfo, A., Moran, B., Das, S. et al. (2017) Fam60a deﬁnes a variant Sin3a-Hdac complex in embryonic stem
cells required for self-renewal. EMBO J. 36, 2216–2232 https://doi.org/10.15252/embj.201696307
44 Banks, C.A.S., Thornton, J.L., Eubanks, C.G., Adams, M.K., Miah, S., Boanca, G. et al. (2018) A structured workﬂow for mapping human Sin3 histone
deacetylase complex interactions using Halo-MudPIT afﬁnity-puriﬁcation mass spectrometry. Mol. Cell. Proteomics 17, 1432–1447 https://doi.org/10.
1074/mcp.TIR118.000661
45 David, G., Turner, G.M., Yao, Y., Protopopov, A. and DePinho, R.A. (2003) mSin3-associated protein, mSds3, is essential for pericentric heterochromatin
formation and chromosome segregation in mammalian cells. Genes Dev. 17, 2396–2405 https://doi.org/10.1101/gad.1109403
© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).3930
Biochemical Journal (2018) 475 3921–3932
https://doi.org/10.1042/BCJ20170314
46 Lechner, T., Carrozza, M.J., Yu, Y., Grant, P.A., Eberharter, A., Vannier, D. et al. (2000) Sds3 (suppressor of defective silencing 3) is an integral
component of the yeast Sin3[middle dot]Rpd3 histone deacetylase complex and is required for histone deacetylase activity. J. Biol. Chem. 275,
40961–40966 https://doi.org/10.1074/jbc.M005730200
47 Meehan, W.J., Samant, R.S., Hopper, J.E., Carrozza, M.J., Shevde, L.A., Workman, J.L. et al. (2004) Breast cancer metastasis suppressor 1 (BRMS1)
forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J. Biol. Chem.
279, 1562–1569 https://doi.org/10.1074/jbc.M307969200
48 Nikolaev, A.Y., Papanikolaou, N.A., Li, M., Qin, J. and Gu, W. (2004) Identiﬁcation of a novel BRMS1-homologue protein p40 as a component
of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex. Biochem. Biophys. Res. Commun. 323, 1216–1222 https://doi.org/10.1016/j.bbrc.
2004.08.227
49 Clark, M.D., Marcum, R., Graveline, R., Chan, C.W., Xie, T., Chen, Z. et al. (2015) Structural insights into the assembly of the histone
deacetylase-associated Sin3L/Rpd3L corepressor complex. Proc. Natl Acad. Sci. U.S.A. 112, E3669–E3678 https://doi.org/10.1073/pnas.1504021112
50 Shiio, Y., Rose, D.W., Aur, R., Donohoe, S., Aebersold, R. and Eisenman, R.N. (2006) Identiﬁcation and characterization of SAP25, a novel component
of the mSin3 corepressor complex. Mol. Cell. Biol. 26, 1386–1397 https://doi.org/10.1128/MCB.26.4.1386-1397.2006
51 Nomura, M., Uda-Tochio, H., Murai, K., Mori, N. and Nishimura, Y. (2005) The neural repressor NRSF/REST binds the PAH1 domain of the Sin3
corepressor by using its distinct short hydrophobic helix. J. Mol. Biol. 354, 903–915 https://doi.org/10.1016/j.jmb.2005.10.008
52 Carrozza, M.J., Li, B., Florens, L., Suganuma, T., Swanson, S.K., Lee, K.K. et al. (2005) Histone H3 methylation by Set2 directs deacetylation of coding
regions by Rpd3S to suppress spurious intragenic transcription. Cell 123, 581–592 https://doi.org/10.1016/j.cell.2005.10.023
53 Keogh, M.C., Kurdistani, S.K., Morris, S.A., Ahn, S.H., Podolny, V., Collins, S.R. et al. (2005) Cotranscriptional set2 methylation of histone H3 lysine 36
recruits a repressive Rpd3 complex. Cell 123, 593–605 https://doi.org/10.1016/j.cell.2005.10.025
54 Nishibuchi, G., Shibata, Y., Hayakawa, T., Hayakawa, N., Ohtani, Y., Sinmyozu, K. et al. (2014) Physical and functional interactions between the histone
H3K4 demethylase KDM5A and the nucleosome remodeling and deacetylase (NuRD) complex. J. Biol. Chem. 289, 28956–28970 https://doi.org/10.
1074/jbc.M114.573725
55 Jelinic, P., Pellegrino, J. and David, G. (2011) A novel mammalian complex containing Sin3B mitigates histone acetylation and RNA polymerase II
progression within transcribed loci. Mol. Cell. Biol. 31, 54–62 https://doi.org/10.1128/MCB.00840-10
56 Bowman, C.J., Ayer, D.E. and Dynlacht, B.D. (2014) Foxk proteins repress the initiation of starvation-induced atrophy and autophagy programs. Nat. Cell
Biol. 16, 1202–1214 https://doi.org/10.1038/ncb3062
57 Cai, Y., Jin, J., Tomomori-Sato, C., Sato, S., Sorokina, I., Parmely, T.J. et al. (2003) Identiﬁcation of new subunits of the multiprotein mammalian
TRRAP/TIP60-containing histone acetyltransferase complex. J. Biol. Chem. 278, 42733–42736 https://doi.org/10.1074/jbc.C300389200
58 Eisen, A., Utley, R.T., Nourani, A., Allard, S., Schmidt, P., Lane, W.S. et al. (2001) The yeast NuA4 and Drosophila MSL complexes contain homologous
subunits important for transcription regulation. J. Biol. Chem. 276, 3484–3491 https://doi.org/10.1074/jbc.M008159200
59 Grzenda, A., Lomberk, G., Zhang, J.S. and Urrutia, R. (2009) Sin3: master scaffold and transcriptional corepressor. Biochim. Biophys. Acta 1789,
443–450 https://doi.org/10.1016/j.bbagrm.2009.05.007
60 Silverstein, R.A. and Ekwall, K. (2005) Sin3: a ﬂexible regulator of global gene expression and genome stability. Curr. Genet. 47, 1–17 https://doi.org/
10.1007/s00294-004-0541-5
61 Brubaker, K., Cowley, S.M., Huang, K., Loo, L., Yochum, G.S., Ayer, D.E. et al. (2000) Solution structure of the interacting domains of the Mad-Sin3
complex: implications for recruitment of a chromatin-modifying complex. Cell 103, 655–665 https://doi.org/10.1016/S0092-8674(00)00168-9
62 Steven, S. (2006) What is a planet? Astron. J. 132, 2513 https://doi.org/10.1086/508861
63 Chandru, A., Bate, N., Vuister, G.W. and Cowley, S.M. (2018) Sin3a recruits Tet1 to the PAH1 domain via a highly conserved Sin3-interaction domain.
Sci. Rep. 8, 14689 https://doi.org/10.1038/s41598-018-32942-w
64 Sahu, S.C., Swanson, K.A., Kang, R.S., Huang, K., Brubaker, K., Ratcliff, K. et al. (2008) Conserved themes in target recognition by the PAH1 and
PAH2 domains of the Sin3 transcriptional corepressor. J. Mol. Biol. 375, 1444–1456 https://doi.org/10.1016/j.jmb.2007.11.079
65 Spronk, C.A., Tessari, M., Kaan, A.M., Jansen, J.F., Vermeulen, M., Stunnenberg, H.G. et al. (2000) The Mad1-Sin3B interaction involves a novel helical
fold. Nat. Struct. Biol. 7, 1100–1104 https://doi.org/10.1038/81944
66 Kumar, G.S., Xie, T., Zhang, Y. and Radhakrishnan, I. (2011) Solution structure of the mSin3A PAH2-Pf1 SID1 complex: a Mad1/Mxd1-like interaction
disrupted by MRG15 in the Rpd3S/Sin3S complex. J. Mol. Biol. 408, 987–1000 https://doi.org/10.1016/j.jmb.2011.03.043
67 Laherty, C.D., Billin, A.N., Lavinsky, R.M., Yochum, G.S., Bush, A.C., Sun, J.M. et al. (1998) SAP30, a component of the mSin3 corepressor complex
involved in N-CoR-mediated repression by speciﬁc transcription factors. Mol. Cell 2, 33–42 https://doi.org/10.1016/S1097-2765(00)80111-2
68 Cowley, S.M., Kang, R.S., Frangioni, J.V., Yada, J.J., DeGrand, A.M., Radhakrishnan, I. et al. (2004) Functional analysis of the Mad1-mSin3A
repressor-corepressor interaction reveals determinants of speciﬁcity, afﬁnity, and transcriptional response. Mol. Cell. Biol. 24, 2698–2709 https://doi.
org/10.1128/MCB.24.7.2698-2709.2004
69 He, Y. and Radhakrishnan, I. (2008) Solution NMR studies of apo-mSin3A and -mSin3B reveal that the PAH1 and PAH2 domains are structurally
independent. Protein Sci. 17, 171–175 https://doi.org/10.1110/ps.073097308
70 Xie, T., He, Y., Korkeamaki, H., Zhang, Y., Imhoff, R., Lohi, O. et al. (2011) Structure of the 30-kDa Sin3-associated protein (SAP30) in complex with
the mammalian Sin3A corepressor and its role in nucleic acid binding. J. Biol. Chem. 286, 27814–27824 https://doi.org/10.1074/jbc.M111.252494
71 van Ingen, H., Lasonder, E., Jansen, J.F., Kaan, A.M., Spronk, C.A., Stunnenberg, H.G. et al. (2004) Extension of the binding motif of the Sin3
interacting domain of the Mad family proteins. Biochemistry 43, 46–54 https://doi.org/10.1021/bi0355645
72 Farias, E.F., Petrie, K., Leibovitch, B., Murtagh, J., Chornet, M.B., Schenk, T. et al. (2010) Interference with Sin3 function induces epigenetic
reprogramming and differentiation in breast cancer cells. Proc. Natl Acad. Sci. U.S.A. 107, 11811–11816 https://doi.org/10.1073/pnas.1006737107
73 Kwon, Y.J., Petrie, K., Leibovitch, B.A., Zeng, L., Mezei, M., Howell, L. et al. (2015) Selective inhibition of SIN3 corepressor with avermectins as a novel
therapeutic strategy in triple-negative breast cancer. Mol. Cancer Ther. 14, 1824–1836 https://doi.org/10.1158/1535-7163.MCT-14-0980-T
74 Bansal, N., David, G., Farias, E. and Waxman, S. (2016) Emerging roles of epigenetic regulator Sin3 in cancer. Adv. Cancer Res. 130, 113–135
https://doi.org/10.1016/bs.acr.2016.01.006
75 Alland, L., David, G., Shen-Li, H., Potes, J., Muhle, R., Lee, H.C. et al. (2002) Identiﬁcation of mammalian Sds3 as an integral component of the
Sin3/histone deacetylase corepressor complex. Mol. Cell. Biol. 22, 2743–2750 https://doi.org/10.1128/MCB.22.8.2743-2750.2002
© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY). 3931
Biochemical Journal (2018) 475 3921–3932
https://doi.org/10.1042/BCJ20170314
76 Yochum, G.S. and Ayer, D.E. (2002) Role for the mortality factors MORF4, MRGX, and MRG15 in transcriptional repression via associations with Pf1,
mSin3A, and Transducin-like enhancer of split. Mol Cell Biol. 22, 7868–7876 https://doi.org/10.1128/MCB.22.22.7868-7876.2002
77 Zhang, P., Du, J., Sun, B., Dong, X., Xu, G., Zhou, J. et al. (2006) Structure of human MRG15 chromo domain and its binding to Lys36-methylated
histone H3. Nucleic Acids Res. 34, 6621–6628 https://doi.org/10.1093/nar/gkl989
78 Murzina, N.V., Pei, X.Y., Zhang, W., Sparkes, M., Vicente-Garcia, J., Pratap, J.V. et al. (2008) Structural basis for the recognition of histone H4 by the
histone-chaperone RbAp46. Structure 16, 1077–1085 https://doi.org/10.1016/j.str.2008.05.006
79 Grandori, C., Cowley, S.M., James, L.P. and Eisenman, R.N. (2000) The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu.
Rev. Cell Dev. Biol. 16, 653–699 https://doi.org/10.1146/annurev.cellbio.16.1.653
80 Ayer, D.E., Laherty, C.D., Lawrence, Q.A., Armstrong, A.P. and Eisenman, R.N. (1996) Mad proteins contain a dominant transcription repression domain.
Mol. Cell. Biol. 16, 5772–5781 https://doi.org/10.1128/MCB.16.10.5772
81 Harbour, J.W. and Dean, D.C. (2000) The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14, 2393–2409 https://doi.org/10.
1101/gad.813200
82 Brehm, A., Miska, E.A., McCance, D.J., Reid, J.L., Bannister, A.J. and Kouzarides, T. (1998) Retinoblastoma protein recruits histone deacetylase to
repress transcription. Nature 391, 597–601 https://doi.org/10.1038/35404
83 Luo, R.X., Postigo, A.A. and Dean, D.C. (1998) Rb interacts with histone deacetylase to repress transcription. Cell 92, 463–473 https://doi.org/10.
1016/S0092-8674(00)80940-X
84 Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J.P. et al. (1998) Retinoblastoma protein represses transcription by
recruiting a histone deacetylase. Nature 391, 601–605 https://doi.org/10.1038/35410
85 Lai, A., Kennedy, B.K., Barbie, D.A., Bertos, N.R., Yang, X.J., Theberge, M.C. et al. (2001) RBP1 recruits the mSIN3-histone deacetylase complex to the
pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Mol. Cell. Biol. 21,
2918–2932 https://doi.org/10.1128/MCB.21.8.2918-2932.2001
86 Cowley, S.M., Iritani, B.M., Mendrysa, S.M., Xu, T., Cheng, P.F., Yada, J. et al. (2005) The mSin3A chromatin-modifying complex is essential for
embryogenesis and T-cell development. Mol. Cell. Biol. 25, 6990–7004 https://doi.org/10.1128/MCB.25.16.6990-7004.2005
87 West, A.C. and Johnstone, R.W. (2014) New and emerging HDAC inhibitors for cancer treatment. J. Clin. Invest. 124, 30–39 https://doi.org/10.1172/
JCI69738
88 Wilting, R.H., Yanover, E., Heideman, M.R., Jacobs, H., Horner, J., van der Torre, J. et al. (2010) Overlapping functions of Hdac1 and Hdac2 in cell
cycle regulation and haematopoiesis. EMBO J. 29, 2586–2597 https://doi.org/10.1038/emboj.2010.136
89 Yamaguchi, T., Cubizolles, F., Zhang, Y., Reichert, N., Kohler, H., Seiser, C. et al. (2010) Histone deacetylases 1 and 2 act in concert to promote the
G1-to-S progression. Genes Dev. 24, 455–469 https://doi.org/10.1101/gad.552310
90 Cantor, D.J. and David, G. (2017) The potential of targeting Sin3B and its associated complexes for cancer therapy. Expert Opin. Ther. Targets 21,
1051–1061 https://doi.org/10.1080/14728222.2017.1386655
91 Dannenberg, J.H., van Rossum, A., Schuijff, L. and te Riele, H. (2000) Ablation of the retinoblastoma gene family deregulates G(1) control causing
immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 14, 3051–3064 https://doi.org/10.1101/gad.847700
92 David, G., Grandinetti, K.B., Finnerty, P.M., Simpson, N., Chu, G.C. and Depinho, R.A. (2008) Speciﬁc requirement of the chromatin modiﬁer mSin3B in
cell cycle exit and cellular differentiation. Proc. Natl Acad. Sci. U.S.A. 105, 4168–4172 https://doi.org/10.1073/pnas.0710285105
93 Grandinetti, K.B., Jelinic, P., DiMauro, T., Pellegrino, J., Fernandez Rodriguez, R., Finnerty, P.M. et al. (2009) Sin3b expression is required for cellular
senescence and is up-regulated upon oncogenic stress. Cancer Res. 69, 6430–6437 https://doi.org/10.1158/0008-5472.CAN-09-0537
94 Rayman, J.B., Takahashi, Y., Indjeian, V.B., Dannenberg, J.H., Catchpole, S., Watson, R.J. et al. (2002) E2f mediates cell cycle-dependent
transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev. 16, 933–947 https://doi.org/10.1101/gad.
969202
95 Sobel, R.E., Cook, R.G., Perry, C.A., Annunziato, A.T. and Allis, C.D. (1995) Conservation of deposition-related acetylation sites in newly synthesized
histones H3 and H4. Proc. Natl Acad. Sci. U.S.A. 92, 1237–1241 https://doi.org/10.1073/pnas.92.4.1237
96 Taddei, A., Roche, D., Sibarita, J.B., Turner, B.M. and Almouzni, G. (1999) Duplication and maintenance of heterochromatin domains. J. Cell Biol.
147, 1153–1166 https://doi.org/10.1083/jcb.147.6.1153
97 Sirbu, B.M., Couch, F.B., Feigerle, J.T., Bhaskara, S., Hiebert, S.W. and Cortez, D. (2011) Analysis of protein dynamics at active, stalled, and collapsed
replication forks. Genes Dev. 25, 1320–1327 https://doi.org/10.1101/gad.2053211
98 Bhaskara, S., Jacques, V., Rusche, J.R., Olson, E.N., Cairns, B.R. and Chandrasekharan, M.B. (2013) Histone deacetylases 1 and 2 maintain S-phase
chromatin and DNA replication fork progression. Epigenetics Chromatin 6, 27 https://doi.org/10.1186/1756-8935-6-27
99 Silverstein, R.A., Richardson, W., Levin, H., Allshire, R. and Ekwall, K. (2003) A new role for the transcriptional corepressor SIN3; regulation of
centromeres. Curr. Biol. 13, 68–72 https://doi.org/10.1016/S0960-9822(02)01401-X
100 Fazzio, T.G., Huff, J.T. and Panning, B. (2008) An RNAi screen of chromatin proteins identiﬁes Tip60-p400 as a regulator of embryonic stem cell
identity. Cell 134, 162–174 https://doi.org/10.1016/j.cell.2008.05.031
101 Zhu, F., Zhu, Q., Ye, D., Zhang, Q., Yang, Y., Guo, X. et al. (2018) Sin3a-Tet1 interaction activates gene transcription and is required for embryonic
stem cell pluripotency. Nucleic Acids Res. 46, 6026–6040 https://doi.org/10.1093/nar/gky347
102 Heideman, M.R., Lancini, C., Proost, N., Yanover, E., Jacobs, H. and Dannenberg, J.H. (2014) Sin3a-associated Hdac1 and Hdac2 are essential for
hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis. Haematologica 99, 1292–1303 https://doi.org/10.3324/haematol.
2013.092643
103 van Oevelen, C., Bowman, C., Pellegrino, J., Asp, P., Cheng, J., Parisi, F. et al. (2010) The mammalian Sin3 proteins are required for muscle
development and sarcomere speciﬁcation. Mol. Cell. Biol. 30, 5686–5697 https://doi.org/10.1128/MCB.00975-10
104 Pellegrino, J., Castrillon, D.H. and David, G. (2012) Chromatin associated Sin3A is essential for male germ cell lineage in the mouse. Dev. Biol.
369, 349–355 https://doi.org/10.1016/j.ydbio.2012.07.006
105 Yao, C., Carraro, G., Konda, B., Guan, X., Mizuno, T., Chiba, N. et al. (2017) Sin3a regulates epithelial progenitor cell fate during lung development.
Development 144, 2618–2628 https://doi.org/10.1242/dev.149708
© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).3932
Biochemical Journal (2018) 475 3921–3932
https://doi.org/10.1042/BCJ20170314
